Beware of Phishing! Do not pass on any personal information to companies unknown to you and not clearly identifiable as Conventus. Warning information
Thank you very much for your interest on the 10th European Congress of Virology.
We look forward to your contributions and thank you in advance for your active participation in the congress! Submit your abstract and become part of the scientific programme of ECV 2027.
Publication
The abstracts are selected by the program committee. Accepted abstracts will be integrated into the program as free lectures or ePosters. All abstracts will be published in JOURNAL.
This section covers innate and adaptive immune responses to viral infections and their exploitation for the development of preventive and therapeutic vaccines and immune therapy. Topics may include immune correlates of protection, antibody and T-cell responses, immune memory, vaccine platforms, adjuvants, and mechanisms of viral immune evasion relevant to vaccine design.
This section focuses on the cellular processes exploited or modified by viruses during entry, replication, assembly and egress. Relevant topics include intracellular trafficking, membrane remodeling, organelle dynamics, cytoskeletal interactions, cell signaling, cell death and advanced cellular models of infection.
This section encompasses the discovery, validation and development of antiviral agents targeting either viral components or host factors required for infection. It includes target identification, screening platforms, structure-based drug design, resistance mechanisms, combination therapies and translation of antiviral candidates toward clinical, veterinary or agronomical application.
This section addresses innovative biomarkers and technologies for the detection, diagnosis, prognosis and monitoring of viral infections. It includes molecular and serological biomarkers, host-response signatures, genomic and transcriptomic approaches, point-of-care diagnostics and biomarkers predictive of disease severity or therapeutic response, including the public health dimension, laboratory surveillance of viral diseases.
This section explores the emergence and re-emergence of viral threats in the context of climate change, globalization, urbanization, land-use change and altered human–animal–environment interactions. It includes One Health surveillance, zoonotic spillover, outbreak prediction, early-warning systems and strategies for pandemic preparedness and response.
This section examines viruses in natural and built environments, including water, wastewater, air, soil, food and surfaces. Topics include environmental persistence and transmission, wastewater-based epidemiology, environmental surveillance, virus detection and inactivation, and the impact of environmental change on viral circulation.
This section addresses how evolutionary and ecological processes shape viral diversity, host range, cross-species transmission, emergence and more generally how they impact on ecosystems. It includes mutation, recombination, reassortment, selection, adaptation, ecological drivers of spillover and the evolutionary dynamics of emerging viruses, as well as the impact viruses can have on the ecosystems themselves.
This section covers advanced imaging approaches for visualizing viruses and virus&host interactions across spatial and temporal scales. Topics include live-cell imaging, single-virus tracking, super-resolution microscopy, correlative microscopy, cryo-imaging and quantitative approaches to study viral entry, trafficking, replication and assembly.
This section focuses on the molecular and cellular interactions that determine the outcome of viral infection. It includes virus–host protein and RNA interactions, receptor engagement, exploitation of cellular pathways, host dependency factors, restriction factors and molecular mechanisms of viral counteraction.
This section addresses viral and host determinants that govern disease severity, tissue tropism, transmission and pathogenicity. It includes viral virulence factors, genetic determinants of host adaptation, host susceptibility factors and molecular mechanisms linking viral replication to tissue damage and disease.
This section highlights emerging experimental and computational technologies that are transforming virology. It includes single-cell approaches, organoids and organ-on-chip systems, spatial biology, genome editing, high-throughput functional screens, artificial intelligence, advanced microscopy and next-generation infection models.
This section focuses on the development, engineering and application of viral vectors for gene delivery and therapeutic intervention or biotechnological use. Topics include established and emerging vector platforms, vector design and optimization, targeting and tissue tropism, transgene expression, genome editing delivery, host immune responses, safety and manufacturing, as well as preclinical translation of viral vector based therapies and other application in the real word, including fields.
This section covers the application of genomics, transcriptomics, proteomics, metabolomics and integrated multi-omics to investigate viruses and virus–host interactions. It includes single-cell omics, spatial omics, systems virology, computational integration and high-throughput approaches for identifying viral and host determinants of infection.
This section explores bacteriophage biology and the molecular, ecological and evolutionary interactions between phages and their prokaryotic hosts. Topics include phage entry and replication, host-range determinants, bacterial antiviral defence, phage counter-defence, co-evolution, phage engineering and therapeutic applications, and the impact of phages on the regulation of the microbiomes in animals, in plants, soils and more generally in the environment.
This section focuses on the structural organization and molecular architecture of viruses and viral macromolecular complexes. It includes cryo-EM, cryo-electron tomography, structural dynamics, viral assembly and uncoating, receptor interactions and structure-guided development of vaccines and antivirals.
This section addresses viruses associated with human and animal cancers and the molecular mechanisms underlying virus-induced transformation. Topics include viral oncogenes, tumour suppressor deregulation, persistence, immune evasion, virus&host interactions and strategies for prevention and treatment of virus-associated malignancies.
Vector borne viruses
This section covers viruses transmitted by arthropod vectors, including mosquitoes, ticks, midges, sandflies, aphids, whiteflies, leafhoppers, planthoppers, and thrips. It encompasses virus biology, vector competence, virus -vector-host interactions, epidemiology, ecological and climatic drivers of transmission, surveillance and strategies for prevention and control.
This section explores the genetic diversity of viruses within hosts, populations and ecosystems and how ecological processes shape viral populations. Topics include viral communities, host&virus networks, metagenomics, population genetics, transmission dynamics and the ecological consequences of viral diversity.
This section addresses long-term virus evolution and the contribution of endogenous viral elements to host genome evolution. Topics include paleovirology, endogenous retroviruses, endogenous/integrated viral sequence in plant genomes, virus-host co-evolution, co-option of viral genes, evolutionary origins of viral lineages and the biological consequences of ancient viral integrations.
This section focuses on the organization, function, diversity and evolution of viral genomes. It includes viral genome sequencing, functional genomics, mutational landscapes, recombination and reassortment, genome-wide screens, genetic determinants of phenotype and computational analysis of viral sequence data.
This section examines the molecular mechanisms through which cells detect and restrict viral infection and the strategies viruses use to counteract these defences. Topics include pattern-recognition receptors, interferon responses, restriction factors, antiviral effectors, immune evasion and virus-driven modulation of innate signaling, RNAi antiviral response, ETI and PTI responses in plants.
This section focuses on the mechanisms that allow viruses to establish and maintain long-term infection despite antiviral immunity and therapy. It includes viral latency, persistent replication, reservoirs, reactivation, immune escape, tissue-specific persistence and novel strategies for eliminating or controlling persistent infections.
This section covers the development of replication-competent viruses as anticancer therapeutics. Topics include engineering and targeting of oncolytic viruses, mechanisms of tumor-selective replication and oncolysis, antitumor immune activation, systemic delivery, arming with immunomodulatory transgenes, combination with checkpoint inhibitors and other therapies, advanced preclinical models and clinical translation.
Publication
As per usual the abstracts will be published in a digital abstract book, which you will receive online shortly before the conference.